Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Accord
FDA Approves ATROPINE SULFATE — Accord Healthcare, Inc.,

Accord Healthcare has received FDA approval for its intravenous atropine sulfate generic under ANDA212868, a move likely to strengthen the company’s f...

BAYER
FDA Approves Unknown Drug — BAYER HLTHCARE

Bayer Healthcare has received FDA approval for an undisclosed new drug product under NDA215341, marking a strategic milestone that is expected to leve...

Meitheal
FDA Approves DAPTOMYCIN — Meitheal Pharmaceuticals Inc.

Meitheal Pharmaceuticals Inc. secured FDA approval for its intravenous Daptomycin, positioning the company to capitalize on the high-value antibiotic ...

Chartwell
FDA Approves OXCARBAZEPINE — Chartwell RX, LLC

# FDA Approves Generic Oxcarbazepine for Chartwell RX Chartwell RX, LLC received FDA approval for its generic oxcarbazepine oral formulation, expandi...

Sun
FDA Approves LEVORPHANOL TARTRATE — Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries, Inc. announced the FDA approval of its ANDA for levophenanol tartrate oral tablets, following the loss of patents prote...

NANG
FDA Approves Unknown Drug — NANG KUANG PHARM CO

# FDA Approves Generic Drug Application for NANG KUANG PHARM CO The FDA has approved ANDA 204329 for Nang Kuang Pharm Co, expanding the company's gen...

Ascend
FDA Approves BUPRENORPHINE AND NALOXONE — Ascend Laboratories, LLC

On June 15, 2021, Ascend Laboratories, LLC received FDA approval for its Abbreviated New Drug Application #214930, introducing a generic version of Bu...

Accord
FDA Approves ARGATROBAN — Accord Healthcare Inc.

# FDA Approves Accord Healthcare's Argatroban Injectable, Expanding Anticoagulant Market Accord Healthcare Inc. received FDA approval for its intrave...

NOVO
FDA Approves Unknown Drug — NOVO

Novo Nordisk announced the U.S. approval of a new medication today, a development that is poised to significantly impact the competitive landscape for...

AJANTA
FDA Approves Unknown Drug — AJANTA PHARMA LTD

Ajanta Pharma’s recent FDA approval for ANDA 212943 positions the company to expand its footprint in the U.S. therapeutic market, potentially driving ...

Merck
FDA Approves NOXAFIL — Merck Sharp & Dohme LLC

# FDA Approves Merck's NOXAFIL (Posaconazole) Oral Formulation Merck Sharp & Dohme LLC has received FDA approval for an oral formulation of NOXAFIL (...

Alkermes,
FDA Approves LYBALVI — Alkermes, Inc.

# FDA Approves Alkermes' LYBALVI for Schizophrenia and Bipolar Disorder Treatment Alkermes, Inc. received FDA approval for LYBALVI (olanzapine and sa...

LGM
FDA Approves Unknown Drug — LGM PHARMA

LGM Pharma announced the approval of its ANDA for a leading antihistamine, marking a significant milestone that positions the company to capitalize on...

Camber
FDA Approves GABAPENTIN — Camber Pharmaceuticals, Inc.

# FDA Approves Gabapentin Generic from Camber Pharmaceuticals The FDA has approved Camber Pharmaceuticals' abbreviated new drug application for gener...

MYLAN
FDA Approves Unknown Drug — MYLAN TECH VIATRIS

Viatris received an FDA approval for an Abbreviated New Drug Application on May 3, 2021, positioning the company for potential market entry and revenu...

ADC
FDA Approves ZYNLONTA — ADC Therapeutics America, Inc.

# FDA Approves ADC Therapeutics' ZYNLONTA for Relapsed or Refractory Diffuse Large B-Cell Lymphoma ADC Therapeutics America, Inc. received FDA approv...

Bionpharma
FDA Approves ATOVAQUONE — Bionpharma Inc.

Bionpharma Inc. announced the approval of the generic drug atovaquone, allowing the company to enter new markets and strengthen its portfolio of acces...

Novo
FDA Approves ZEGALOGUE — Novo Nordisk

The U.S. Food and Drug Administration has approved dasiglucagon (ZEGALOGUE) from Novo Nordisk for the emergency treatment of severe hypoglycemia cause...

Encube
FDA Approves CLINDAMYCIN PHOSPHATE — Encube Ethicals, Inc.

# FDA Approves Encube Ethicals' Generic Clindamycin Phosphate Gel Encube Ethicals, Inc. received FDA approval for its generic clindamycin phosphate g...

Leading
FDA Approves DOXEPIN HYDROCHLORIDE — Leading Pharma, LLC

Leading Pharma, LLC announced the FDA approval of its ANDA for doxepin hydrochloride on March 9, 2021, enabling the launch of this oral anticholinergi...